Local Orbital Therapy for Thyroid Eye Disease
Methods of treating acute thyroid eye disease (TED) by administering a inhibitor, e.g., a VEGF-A inhibitor, e.g., an anti-VEGF antibody, optionally in combination with hyaluronidase, by periorbital or intraorbital injection. Also compositions comprising a VEGF inhibitor and hyaluronidase.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
12.09.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methods of treating acute thyroid eye disease (TED) by administering a inhibitor, e.g., a VEGF-A inhibitor, e.g., an anti-VEGF antibody, optionally in combination with hyaluronidase, by periorbital or intraorbital injection. Also compositions comprising a VEGF inhibitor and hyaluronidase. |
---|---|
Bibliography: | Application Number: US201716307411 |